Status:
COMPLETED
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
Lead Sponsor:
Organon and Co
Conditions:
Postmenopausal Osteoporosis
Eligibility:
FEMALE
25+ years
Phase:
PHASE3
Brief Summary
This study is to evaluate and compare the effects of Alendronate and Risedronate to treat women with postmenopausal osteoporosis. The primary hypothesis for this study is that in postmenopausal women ...
Eligibility Criteria
Inclusion
- Women with postmenopausal osteoporosis
Exclusion
- Bilateral hip replacements
- Esophageal abnormalities
- Metabolic bone disease (example - Vitamin D deficiency)
- Medications that would affect the breakdown or build-up of bone turnover
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2004
Estimated Enrollment :
1053 Patients enrolled
Trial Details
Trial ID
NCT00092014
Start Date
September 1 2002
End Date
April 1 2004
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.